A nanoplatform combines silver nanoparticles and a Schiff-base structure to eradicate drug-resistant tuberculosis, indicating enhanced bactericidal action.
An integrated triple anti-tuberculosis nanoplatform was developed, leveraging a synergistic combination of silver nanoparticles, EPL, and a Schiff-base structure to effectively eliminate drug-resistant Mycobacterium tuberculosis .
No takes yet. Share an insight, caveat, or question.
Song et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: